U.S. Healthcare Services Stock News

Why Gossamer Bio’s PROSERA readout matters now Gossamer Bio (GOSS) has drawn fresh attention after releasing topline Phase 3 PROSERA data for seralutinib in pulmonary arterial hypertension and scheduling a special call to review the results and potential next steps with regulators. See our latest analysis for Gossamer Bio. The unveiling of the PROSERA Phase 3 topline data and the planned FDA discussions come after a sharp reset in sentiment, with a 30 day share price return of 84.32% decline...

If you are wondering whether OFG Bancorp at around US$41.39 is still good value or already pricing in a lot of optimism, you are asking the right question. The stock has had mixed recent returns, with a 1.2% decline over the last 7 days, an 11.4% gain over 30 days, 0.9% year to date, 2.4% over 1 year, 50.3% over 3 years and 134.3% over 5 years, which can change how investors think about both upside and risk. Recent news around OFG Bancorp has focused on its position as a US regional bank and...

Ategrity Specialty Insurance Company Holdings (ASIC) has drawn fresh attention after a sharp recent move in its share price, with the stock up 6.1% over the past day and 32.7% in the past week. See our latest analysis for Ategrity Specialty Insurance Company Holdings. The recent surge in Ategrity Specialty Insurance Company Holdings’ share price, including a 32.7% 7 day share price return and a 23.97% 90 day share price return, suggests short term momentum is building while year to date...

Kinetik Holdings (NYSE:KNTK) is reported to be exploring a potential sale process. Western Midstream Partners has shown interest in a possible acquisition of Kinetik Holdings. The situation points to possible changes in ownership structure and future direction for the company. Kinetik Holdings, listed on the NYSE under ticker KNTK, operates in the midstream energy space, connecting upstream production with downstream demand through gathering, processing, and related services. Attention on...

Crinetics Pharmaceuticals (NasdaqGS:CRNX) reported positive clinical trial results for its congenital adrenal hyperplasia treatment. The company also announced positive initial sales for its oral therapy for acromegaly, alongside progress on related regulatory milestones. These updates highlight recent clinical and commercial developments in Crinetics' rare endocrine disease portfolio. Crinetics Pharmaceuticals focuses on therapies for rare endocrine conditions, an area where treatment...

CarGurus, NasdaqGS:CARG, has authorized a new $250 million share repurchase program. The company is sharpening its focus on its core marketplace and international growth after winding down CarOffer. Management highlighted strong revenue, record retention, and faster dealer acquisition, including outside the US. CarGurus, trading at $27.86, sits at an interesting crossroads, with a 3-year return of 63.4% and a 5-year return of 5.5%. In the shorter term, the stock is down 18.1% over the past...

Wondering if Wynn Resorts at around US$107 is offering value today or if the easy money has already been made? This article is designed to help you frame that question clearly. The stock is down about 5.4% over the last week and 5.5% over the last month, yet it still shows a 20.1% return over the past year. That combination can change how you think about both upside potential and risk. Recent coverage has focused on Wynn Resorts as a major casino and resort operator with exposure to both...

Earlier in February 2026, Bank of Hawaii Corporation disclosed that Director Robert W. Wo Jr., through the Robert Ching Wo Trust 1985, sold 5,000 indirectly held common shares, while the bank also confirmed its CEO plans to retire at the end of March 2026. The combination of leadership transition and insider share sale has sharpened investor focus on how Bank of Hawaii will manage succession and governance continuity. We’ll now examine how the CEO’s planned retirement may influence Bank of...

Stepan (SCL) has wrapped up FY 2025 with fourth quarter revenue of US$553.9 million and basic EPS of US$0.22, while trailing twelve month figures show revenue of about US$2.3 billion and EPS of US$2.05. Over recent periods, revenue has moved from US$546.8 million in Q3 2024 to the US$590.3 million to US$594.7 million range across the first three quarters of 2025, with quarterly EPS ranging from US$0.47 to US$0.86, and trailing EPS shifting between US$2.01 and US$2.54. With a trailing net...

In February 2026, Forum Energy Technologies reported that Q4 2025 sales were US$202.2 million with net income of US$2.07 million, while completing a US$35.00 million buyback of 1.40 million shares, or 11.68% of its stock, under the repurchase plan announced in December 2024. The company exited 2025 with a US$312.0 million order backlog, the largest in 11 years, and issued 2026 guidance calling for US$800.0–US$880.0 million in revenue, highlighting how improved earnings, a stronger order...

CubeSmart (NYSE:CUBE) has entered a $250 million joint venture with CBRE Investment Management. The partnership is focused on expanding CubeSmart's presence in high growth self storage markets. The new venture comes as the self storage market shows signs of recovery and renewed investor interest. For investors watching NYSE:CUBE at a share price of $39.66, this move adds a fresh layer to the story. The stock is up 12.0% year to date and has returned 34.6% over 5 years, while 1 year and 3...

Community Financial System (NYSE:CBU) has appointed Brenda M. Hall as a new independent director to its Board. Hall previously served as chief operating officer in the insurance industry, with experience in enterprise strategy, risk management, and regulatory oversight. The appointment is intended to deepen the Board’s expertise in governance and oversight for shareholders and other stakeholders. Community Financial System, the parent of Community Bank, operates as a regional financial...

Casella Waste Systems (NasdaqGS:CWST) has completed nine acquisitions, adding more than $115 million in annualized revenues. The company outlined an active pipeline of additional deals it aims to pursue in 2026. Management framed the acquisition push as a key lever for scaling operations and driving efficiencies across the business. For investors following NasdaqGS:CWST, this deal streak comes at a time when the stock is trading at $92.71 and has seen a 17.2% decline over the past year,...

Saia (NasdaqGS:SAIA) is facing ongoing sales volume challenges over the last two years and has leaned on price increases to support revenue. At the same time, the company has stepped up investment activity, which has pressured cash flows. Returns on capital have declined, raising questions about whether Saia’s traditional profit drivers are maturing. Saia operates in the less than truckload freight sector, where pricing power and network efficiency matter as much as demand trends. For you...

In February 2026, Similarweb reported fourth-quarter 2025 revenue of US$72.76 million and a net loss of US$7.5 million, alongside full-year 2025 revenue of US$282.6 million and a net loss of US$32.94 million, while issuing 2026 revenue guidance of US$305.0–US$315.0 million and unveiling its new AI Studio enterprise intelligence platform. The combination of accelerating AI-focused product development, including AI Studio and rising AI-related revenue contributions, with widening losses and...

Veris Residential (VRE) has wrapped up FY 2025 with Q4 revenue of US$71.3 million, basic EPS near breakeven at about US$0.00, and a small net loss from continuing operations of US$0.4 million, while trailing twelve month EPS stood at US$0.77 on revenue of US$288.4 million. Over recent periods, the company has seen quarterly revenue range from US$68.1 million in Q3 2024 to US$76.4 million in Q2 2025. Basic EPS moved from a loss of US$0.29 on a trailing basis in Q4 2024 to a profit of US$0.77...

American Financial Group, NYSE:AFG, released fresh results alongside updated guidance and continued capital return actions. The company also approved a new long term executive incentive compensation plan focused on performance alignment. These developments provide new information on operating trends and how leadership is being incentivized over time. For shareholders watching NYSE:AFG, the new report and guidance come with some context. The stock closed at $129.61, with a 1 year return of...

If you are wondering whether Diversified Healthcare Trust is still reasonably priced after its recent run, you are not alone. This article will walk through what the current share price might be implying about value. The stock closed at US$6.15, with a 6.1% decline over the last 7 days, an 8.7% gain over 30 days, a 23.5% gain year to date, a 158.1% gain over 1 year, and a very large gain over 3 years, while the 5 year return sits at 44.5%. Recent headlines have focused on Diversified...

Eversource Energy (NYSE:ES) has announced new fixed to floating rate junior subordinated notes due 2056. The securities feature a fixed coupon initially, then switch to a floating rate after a future reset date. The notes are callable and are ranked junior to senior debt, which affects both risk and potential yield for buyers. Eversource Energy, a major regulated utility serving New England, relies on capital markets to fund grid investments, maintenance, and broader infrastructure needs...

Jumia Technologies (JMIA) has come into focus after reporting fourth quarter and full year 2025 results, with sales of US$61.4 million and a net loss of US$10.31 million in the quarter. See our latest analysis for Jumia Technologies. Even with the latest earnings showing higher sales and a smaller quarterly net loss, Jumia Technologies' recent 30 day share price return of a 34.91% decline and year to date share price return of a 34.61% decline contrast with a very large 1 year total...

ORIC Pharmaceuticals (NasdaqGS:ORIC) reports progress in its cancer therapy pipeline, with lead drug candidates entering Phase 1b clinical trials. The company announces new collaborations with Pfizer, Bayer, and Johnson & Johnson, aimed at advancing therapies that target resistance mechanisms in cancer treatment. These developments are drawing increased investor attention as they represent material steps in ORIC Pharmaceuticals' clinical and partnership strategy. ORIC Pharmaceuticals...

ARMOUR Residential REIT (NYSE:ARR) reported robust Q4 2025 results, highlighting portfolio growth and higher book value. The company affirmed its dividend, signaling confidence in the stability of its payout. Management outlined updated plans for capital deployment and risk management in what it views as a supportive market backdrop. The portfolio update included a focus on lower coupon and seasoned mortgage-backed securities to address prepayment risk. ARR also raised fresh capital and...

In February 2026, Bausch Health Companies reported fourth-quarter 2025 revenue of US$2,796 million and a net loss of US$112 million, alongside full-year 2025 revenue of US$10.27 billion, net income of US$157 million, and a US$145 million goodwill impairment, while also issuing 2026 revenue guidance of US$10.63–US$10.88 billion. A day later, the company and its OraPharma dental unit marked the 25th anniversary of ARESTIN, currently the only FDA-approved locally applied antibiotic adjunct for...

Why insiders are buying Conduent stock after recent EBITDA progress Recent insider share purchases at Conduent (CNDT), including buying by the CEO and a director, have drawn attention as the company reports higher full year 2025 adjusted EBITDA and improved margins despite lower revenue. See our latest analysis for Conduent. The insider buying comes after a sharp move in the 1 day share price return of 11.19% and a 7 day gain of 3.58%, although the 1 year total shareholder return of 57.6% and...